Connecticut 2013 Regular Session

Connecticut Senate Bill SB00838

Introduced
2/7/13  
Refer
2/7/13  
Report Pass
3/7/13  
Report Pass
4/16/13  
Report Pass
4/16/13  
Refer
4/26/13  
Refer
4/26/13  
Report Pass
5/2/13  

Caption

An Act Establishing A Fund For Bioscience Innovation.

Impact

The bill emphasizes the state's commitment to enhancing its bioscience industry, creating a streamlined process for financial support. By authorizing the establishment of an advisory committee, the legislation facilitates the oversight of financial assistance processes and ensures that assistance aligns with state-wide health and economic goals. In addition, the potential return on investment from awarded financial assistance is designed to eventually replenish the fund, enabling it to sustain its operations over the long term and encourage continued innovation in healthcare-related fields.

Summary

SB00838 establishes the Connecticut Bioscience Innovation Fund, aimed at fostering growth within the bioscience sector through financial assistance to eligible recipients, which include accredited colleges, nonprofit organizations, and early-stage businesses. The fund will primarily support projects focused on health information management, medical devices, pharmaceuticals, and related fields expected to improve healthcare services and stimulate job growth in Connecticut. It intends to allocate a total of $200 million in bonds for funding purposes across various fiscal years, starting with $10 million in the first fiscal year.

Sentiment

Overall, the sentiment around SB00838 appears supportive, particularly among stakeholders in the bioscience industry and higher education sectors, who see this as a significant step towards elevating Connecticut's position in the competitive global bioscience marketplace. However, details concerning fund management and accountability will likely be areas of scrutiny, as transparency in the allocation of financial aid is crucial for community trust and effective use of state resources.

Contention

While proponents celebrate the establishment of the fund for its potential economic benefits, concerns about possible mismanagement or lack of focus on immediate health disparities may arise. Advocacy groups and some legislators may debate the prioritization of funding for specific technology applications over more holistic healthcare needs, urging the need for that financial resources target measurable health improvements across communities. The ongoing discussions will likely shape how effectively the fund operates in achieving its stated goals.

Companion Bills

No companion bills found.

Similar Bills

CT SB00401

An Act Concerning The Connecticut Bioscience Innovation Fund And Investments By Connecticut Innovations, Incorporated.

CT SB01026

An Act Concerning A Marketing Plan To Promote The Bioscience Industry In The State.

CT HB05042

An Act Concerning The Regenerative Medicine Research Fund.

CT SB00842

An Act Authorizing And Adjusting Bonds Of The State For Capital Improvements, Transportation, Elimination Of The Accumulated Gaap Deficit And Other Purposes.

CT SB00959

An Act Concerning Penalties For The Filing Of Paper Documents With The Department Of Revenue Services.

CT SB00840

An Act Concerning Next Generation Connecticut.

CT SB00957

An Act Concerning Revisions To The Regenerative Medicine Research Fund And The Connecticut Bioscience Innovation Fund, And The Consolidation Of Certain Funds Of Connecticut Innovations, Incorporated.

CT SB00029

An Act Authorizing And Adjusting Bonds Of The State For Capital Improvements, Transportation And Other Purposes, And Concerning Miscellaneous Programs, Including The Smart Start Program, The Water Improvement System Program, School Security Grants, The Regenerative Medicine Research Fund, The Connecticut Manufacturing Innovation Fund And The Board Of Regents For Higher Education Infrastructure Act.